Athina Ganner

1.9k total citations · 1 hit paper
23 papers, 963 citations indexed

About

Athina Ganner is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Athina Ganner has authored 23 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Athina Ganner's work include Genetic and Kidney Cyst Diseases (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Renal and related cancers (5 papers). Athina Ganner is often cited by papers focused on Genetic and Kidney Cyst Diseases (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Renal and related cancers (5 papers). Athina Ganner collaborates with scholars based in Germany, United States and Switzerland. Athina Ganner's co-authors include Gerd Walz, Joachim Gloy, Matias Simons, Tomoko Obara, Bozena Polok, Olga A. Cabello, Thomas Benzing, Mikhail Bashkurov, Andreas Jenny and Wolfgang Driever and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Athina Ganner

21 papers receiving 950 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways

2005 588 citations Matias Simons, Joachim Gloy et al. Nature Genetics profile →

Peers

Countries citing papers authored by Athina Ganner

Since Specialization

Citations

This map shows the geographic impact of Athina Ganner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athina Ganner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athina Ganner more than expected).

Fields of papers citing papers by Athina Ganner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athina Ganner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athina Ganner. The network helps show where Athina Ganner may publish in the future.

Co-authorship network of co-authors of Athina Ganner

This figure shows the co-authorship network connecting the top 25 collaborators of Athina Ganner. A scholar is included among the top collaborators of Athina Ganner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athina Ganner. Athina Ganner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proteomic characterization of the pseudocapsule of clear cell renal cell carcinoma in VHL disease reveals a distinct microenvironment at the tumor boundary zone 2025 ·Neoplasia ·(unknown), Manuel Rogg, (unknown), Niko Pinter, Maximilian Wess, (unknown), (unknown), Elke Neumann‐Haefelin, Athina Ganner, Markus Grabbert, Christoph Schell, Oliver Schilling	0
2	Nonstop mutations cause loss of renal tumor suppressor proteins VHL and BAP1 and affect multiple stages of protein translation 2025 ·Science Advances ·(unknown), (unknown), Athina Ganner, (unknown), Sonam Dhamija, (unknown), (unknown), Ian J. Frew, Fruzsina Kotsis, Elke Neumann‐Haefelin, Anne Spang, Sven Diederichs	1
3	Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors – a retrospective single center analysis 2025 ·BMC Cancer ·(unknown), Fruzsina Kotsis, Athina Ganner, (unknown), (unknown), (unknown), Cordula A. Jilg, Jan‐Helge Klingler, Elke Neumann‐Haefelin	0
4	Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease 2024 ·Journal of Neuro-Oncology ·(unknown), (unknown), (unknown), Nicolas Neidert, (unknown), Elke Neumann‐Haefelin, Athina Ganner, Fruzsina Kotsis, T. Schäfer, Hartmut P.H. Neumann, (unknown), Jürgen Beck, Jan‐Helge Klingler	2
5	Saturation genome editing maps the functional spectrum of pathogenic VHL alleles 2024 ·Nature Genetics ·(unknown), (unknown), Athina Ganner, Laura Cubitt, (unknown), Dong‐Kyu Kim, (unknown), (unknown), (unknown), Joachim De Jonghe, Scott T.C. Shepherd, Chelsea Sawyer, (unknown), Sven Diederichs, Elke Neumann‐Haefelin, Samra Turajlic, Evgueni A. Ivakine, Gregory M. Findlay	16
6	VHL-dependence of EHHADH Expression in a Human Renal Cell Carcinoma Cell Line 2024 ·SHILAP Revista de lepidopterología ·(unknown), Marinella Klein, Elke Neumann‐Haefelin, Athina Ganner	2
7	SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC 2023 ·Cells ·Athina Ganner, (unknown), Simon Lagies, (unknown), Lu Wang, (unknown), Thomas Welte, (unknown), Soeren S. Lienkamp, Marinella Klein, Bernd Kammerer, Ian J. Frew, (unknown), Elke Neumann‐Haefelin	4
8	Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study 2023 ·BMC Nephrology ·Thomas Welte, (unknown), (unknown), (unknown), Martin J. Hug, Elke Neumann‐Haefelin, Athina Ganner	13
9	Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma 2023 ·Cells ·(unknown), Simon Lagies, (unknown), (unknown), (unknown), Athina Ganner, Dietmar A. Plattner, Elke Neumann‐Haefelin, Mojca Adlesic, Ian J. Frew, Bernd Kammerer	9
10	Ift88, but not Kif3a, is required for establishment of the periciliary membrane compartment 2021 ·Biochemical and Biophysical Research Communications ·Fruzsina Kotsis, (unknown), Yujie Li, Amandine Viau, Daniel Epting, Albrecht Kramer-Zucker, Gerd Walz, Roland Nitschke, Esben Lorentzen, Athina Ganner, Elke Neumann‐Haefelin, E. Wolfgang Kuehn, Christopher Boehlke	1
11	VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma 2021 ·Scientific Reports ·Athina Ganner, Christina Gehrke, Marinella Klein, (unknown), (unknown), (unknown), Lu Wang, (unknown), (unknown), (unknown), Fruzsina Kotsis, Gerd Walz, Ian J. Frew, Elke Neumann‐Haefelin	29
12	Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report 2020 ·Transplantation Proceedings ·(unknown), Athina Ganner, Johanna Schneider, (unknown), Gerd Walz, Przemyslaw Pisarski, (unknown), Stefan Zschiedrich	5
13	The acetyltransferase p300 regulates NRF2 stability and localization 2020 ·Biochemical and Biophysical Research Communications ·Athina Ganner, (unknown), (unknown), (unknown), Marinella Klein, Gerd Walz, Elke Neumann‐Haefelin	48
14	CBP-1/p300 acetyltransferase regulates SKN-1/Nrf cellular levels, nuclear localization, and activity in C. elegans 2019 ·Experimental Gerontology ·Athina Ganner, (unknown), (unknown), Yujie Li, (unknown), (unknown), (unknown), G. Breves, Marinella Klein, Gerd Walz, Elke Neumann‐Haefelin	19
15	CGEF-1 regulates mTORC1 signaling during adult longevity and stress response in C. elegans 2018 ·Oncotarget ·Yujie Li, (unknown), Athina Ganner, (unknown), Marinella Klein, (unknown), (unknown), (unknown), Kathrin Thedieck, G. Breves, Thomas Jank, Ralf Baumeister, Gerd Walz, Elke Neumann‐Haefelin	7
16	Genetic kidney diseases: Caenorhabditis elegans as model system 2017 ·Cell and Tissue Research ·Athina Ganner, Elke Neumann‐Haefelin	18
17	Inversin, Wnt signaling and primary cilia 2011 ·Differentiation ·Soeren S. Lienkamp, Athina Ganner, Gerd Walz	77
18	Genetic and physical interaction between the NPHP5 and NPHP6 gene products 2008 ·Human Molecular Genetics ·Tobias Schäfer, Michael Pütz, Soeren S. Lienkamp, Athina Ganner, Astrid Bergbreiter, Haribaskar Ramachandran, (unknown), Martin Gerner, (unknown), Peter G. Czarnecki, John A. Sayer, Edgar A. Otto, Friedhelm Hildebrandt, Albrecht Kramer-Zucker, Gerd Walz	62
19	Successful liver transplantation in a kidney and pancreas allograft recipient with fulminant herpes simplex virus type 2 hepatitis 2007 ·Nephrology Dialysis Transplantation ·Athina Ganner, (unknown), (unknown), Annette Schmitt‐Graeff, Jens Encke, Gerd Walz, Peter Gerke	9
20	Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways breakdown → 2005 ·Nature Genetics ·Matias Simons, Joachim Gloy, Athina Ganner, (unknown), Mikhail Bashkurov, (unknown), Bernhard Schermer, Thomas Benzing, Olga A. Cabello, Andreas Jenny, Marek Mlodzik, Bozena Polok, Wolfgang Driever, Tomoko Obara, Gerd Walz	588

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact